Ascendis Pharma
ASND
ASND
187 hedge funds and large institutions have $8.05B invested in Ascendis Pharma in 2022 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 69 increasing their positions, 69 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 182 → 187 (+5)
0% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 69
8.25% less ownership
Funds ownership: 123.86% → 115.61% (-8.2%)
Holders
187
Holding in Top 10
20
Calls
$110M
Puts
$23.3M
Top Buyers
| 1 | +$97.2M | |
| 2 | +$50.1M | |
| 3 | +$46.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$30.5M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$30.4M |
Top Sellers
| 1 | -$492M | |
| 2 | -$75.6M | |
| 3 | -$74.6M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$50.8M |
| 5 |
Goldman Sachs
New York
|
-$41.4M |